Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant
Donors <18 years are associated with reduced aGVHD and cGVHD, whereas maternal donors are associated with increased cGVHD risk. For pediatric patients, sibling donors should be considered to reduce GVHD.
Authors
- Rishikesh Chavan
- Erin Doherty (ORCID: https://orcid.org/0000-0002-1555-4124)
- Nicole Liberio
- Heather J. Symons
- Mariam Allbee-Johnson
- Sandhya Kharbanda (ORCID: https://orcid.org/0000-0002-6014-7659)
- Rachel Phelan (ORCID: https://orcid.org/0000-0001-5252-9991)
- Christine L. Phillips
- Parinda A. Mehta
- Kristin Page
- Neena Kapoor
- Javier Bolaños-Meade
- Kirk R. Schultz
- Christopher C. Dvorak
- Akshay Sharma
- Muna Qayed
- Amanda E. Lipsitt
- Bronwen E. Shaw
- Larisa Broglie
- Amy Moskop
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Children's Hospital of Orange County (US)
- St. Jude Children's Research Hospital (US)
- Children's Hospital of Los Angeles (US)
- University of British Columbia (CA)
- Johns Hopkins University (US)
- Emory University (US)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- Johns Hopkins Medicine (US)
- Methodist Children’s Hospital (US)
- UCSF Benioff Children's Hospital (US)
- Children's Healthcare of Atlanta (US)
- Texas Children's Hospital (US)
- BC Children's Hospital (CA)
- Sidney Kimmel Comprehensive Cancer Center (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1200/jco-25-01591
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00